Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis

1 Nov 2019

Abstract excerpt

OBJECTIVE: ATRX is a multifunctional protein that is tightly regulated by and implicated in transcriptional regulation and chromatin remodeling. Numerous studies have shown that genetic alterations in ATRX play a significant role in gliomas. This study aims to further determine the relationship between ATRX and glioma prognosis and identify possible mechanisms for exploring the biological significance of ATRX...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Genetics and Neurodevelopmental Disorders
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31908895
DOI: 10.20892/j.issn.2095-3941.2019.0143

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosisPMID 31908895Read ↗

The Role of ATRX in Glioma BiologySemantic proximity Read ↗

ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples.Semantic proximity Read ↗

Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas.Semantic proximity Read ↗

Genomic Profiling in Glioma Patients to Explore Clinically Relevant Markers.Semantic proximity Read ↗

Mutant ATRX: uncovering a new therapeutic target for glioma.Semantic proximity Read ↗

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.Semantic proximity Read ↗

ZMYND8 as a novel diagnostic and prognostic biomarker in GliomaSemantic proximity Read ↗

A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer DatabaseSemantic proximity Read ↗

Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas.Semantic proximity Read ↗

A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.Semantic proximity Read ↗

Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.Semantic proximity Read ↗

Functional Assessment of ATRX Alterations Improves Glioma DiagnosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.